Daiichi Sankyo (OTCMKTS:DSNKY) Sees Strong Trading Volume – Here’s What Happened

Shares of Daiichi Sankyo Co., Ltd. – Sponsored ADR (OTCMKTS:DSNKYGet Free Report) saw unusually-high trading volume on Wednesday . Approximately 353,940 shares were traded during trading, an increase of 39% from the previous session’s volume of 253,888 shares.The stock last traded at $26.48 and had previously closed at $26.98.

Wall Street Analysts Forecast Growth

Separately, Nomura Securities upgraded Daiichi Sankyo to a “strong-buy” rating in a research report on Friday, June 6th. One investment analyst has rated the stock with a Strong Buy rating, According to MarketBeat, the company currently has a consensus rating of “Strong Buy”.

Read Our Latest Stock Report on Daiichi Sankyo

Daiichi Sankyo Trading Down 3.9%

The company has a 50 day moving average of $23.84 and a 200 day moving average of $24.15. The company has a current ratio of 2.53, a quick ratio of 1.85 and a debt-to-equity ratio of 0.06. The firm has a market cap of $47.87 billion and a price-to-earnings ratio of 24.53.

Daiichi Sankyo Company Profile

(Get Free Report)

Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.

Further Reading

Receive News & Ratings for Daiichi Sankyo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Daiichi Sankyo and related companies with MarketBeat.com's FREE daily email newsletter.